ActnerLab

ActnerLab is a venture capital and accelerator firm based in Seoul, South Korea, established in 2012. It specializes in supporting startups in hardware, Internet of Things (IoT), and biotechnology sectors, aiding them in establishing their initial foothold and advancing their growth. The firm focuses on various markets, including bio and medical, healthcare, big data and artificial intelligence, wearable technology, human interfaces, and advanced materials. Through its investment and acceleration programs, ActnerLab aims to foster innovation and development within these dynamic industries.

Inje cho

Founder and CEO

114 past transactions

Chain Lightning

Seed Round in 2022
Chain Lightning is a company focused on enhancing the electric vehicle (EV) experience through its innovative app-based platform. The platform offers a range of services, including locating charging stations, scheduling charging sessions, and managing EV battery health. Additionally, Chain Lightning provides users with educational content related to electric vehicles and eco-friendly living, promoting sustainable practices among EV owners. By integrating charge management and payment services, Chain Lightning aims to facilitate a seamless and efficient charging experience for electric vehicle users.

K-Bio HealthCare

Venture Round in 2022
K-Bio HealthCare provides a personalized health record (PHR) and PHR-based digital healthcare system.

SubµLED

Venture Round in 2022
SubµLED develops and mass produces micro LED light source PKG, which is a key component of next-generation displays.

Healicure

Venture Round in 2022
Healicure is a next-generation hub platform company that connects digital healthcare services through collaboration with experts in various fields.

Dexelion

Venture Round in 2022
Dexelion is a technology company that specializes in software solutions for real-time depth map extraction from commercial CMOS Image Sensor-based cameras, including those utilizing Dual- and Quad-pixel sensors. The company's innovative technology allows for the generation of depth and three-dimensional object models using a single camera without the need for active light sources. This approach achieves minimal power consumption, a compact footprint, and reduced costs, making it suitable for mobile and embedded systems. By providing an effective means for depth map extraction, Dexelion enables its customers to enhance their applications in various fields, including imaging and computer vision.

Moth

Venture Round in 2022
Moth is a manufacturer focused on enhancing sustainable marine industries through innovative materials and technology. The company specializes in the production of propellers designed for both marine and aerospace vehicles, utilizing advanced carbon composites. These propellers are engineered to improve propulsion efficiency, which in turn facilitates easier and shorter maintenance periods for maritime and aerospace companies. Moth aims to contribute to the sustainability of these industries by providing high-performance solutions that meet the evolving demands of the market.

Four-chains

Venture Round in 2022
Four-chains is an R&D company that researches and develop cryptographic schemas, A.I. algorithms, and blockchain-based data security platforms.

AltMedical

Venture Round in 2022
AltMedical is a research institute jointly established with Dong-A University, and aims to develop a treatment for Alzheimer's disease.

Daree Technology

Venture Round in 2022
DaRee Technology is a startup focused on developing wearable robotics aimed at supporting industrial workers, particularly those with physical challenges and musculoskeletal disorders. The company aims to enhance the capabilities of its users, enabling them to perform tasks more efficiently and safely in demanding work environments. By creating innovative solutions tailored for individuals facing physical limitations, DaRee Technology addresses a crucial need in the workforce, promoting inclusivity and improving overall productivity.

C&SR

Venture Round in 2022
C&SR is a biotechnology company specializing in research and development for cancer drug therapies. It focuses on creating humanized animal models for testing drug candidates, utilizing high percentages of human immune cells to generate reliable data. This enables the medical research market to develop new drugs with enhanced safety and efficacy.

Perazah

Venture Round in 2022
Perazah is a medical technology company focused on developing innovative devices aimed at improving patient outcomes across various medical conditions. The company specializes in creating surgical and vascular intervention robots that leverage artificial intelligence to enhance the accuracy of medical procedures. By providing 2D and 3D medical imaging data and procedural guidance, Perazah's technology helps reduce radiation exposure for both patients and operators. Their solutions are designed to assist surgeons and medical professionals in enhancing surgical procedures, chemotherapy, and ENT treatments, ultimately aiming to deliver significant benefits to a diverse range of patients.

Myco-Rapha

Venture Round in 2022
Myco-Rapha is a research and development company focused on combating tuberculosis through innovative solutions. It specializes in the development of a next-generation vaccine aimed at replacing the traditional BCG vaccine, addressing the significant challenges posed by tuberculosis. Additionally, Myco-Rapha has created a field-applied diagnostic method for the early detection of tuberculosis in patients, facilitating timely intervention and treatment. By advancing these technologies, the company aims to eradicate tuberculosis and alleviate the suffering it causes.

V-Memory

Seed Round in 2021
V-Memory is a technology company specializing in semiconductor manufacturing solutions. It focuses on producing thermoelectric semiconductors aimed at enhancing the speed and density of memory cells. The company develops solid-state cooling semiconductors that offer higher efficiency, alongside advanced memory semiconductor technology that delivers improved performance. By providing next-generation semiconductor memory with extended longevity, V-Memory addresses energy distribution imbalances and meets the evolving demands of the technology sector.

AIoT Holdings

Venture Round in 2021
AIoT Holdings is a software development company specializing in the research and development of advanced technologies in artificial intelligence, the Internet of Things, and blockchain. The company focuses on identity authentication solutions utilizing SecureMPC technology, which enhances security in digital transactions. It also develops digital asset security products, including a digital asset vault that employs multi-party computation to ensure the stability, security, and reliability of digital asset storage. Through these innovations, AIoT Holdings aims to provide users with enhanced security measures and peace of mind when managing their digital assets.

Conecson

Venture Round in 2021
Conecson is a developer of innovative portable medical devices that provide users with access to medical services outside of traditional healthcare settings. The company specializes in a mobile-based integrated diagnostic device designed to assist healthcare professionals. Its offerings include telemedicine solutions, self-examination tools, volunteer medical services, medical education, and pre-diagnosis support for long-distance travel. Conecson's technology features a telemedicine examination device and a wireless endoscope camera, which enable video data sharing and remote control of endoscopy procedures. This approach helps healthcare practitioners address spatial limitations and improve diagnostic capabilities in areas typically underserved by conventional healthcare infrastructure.

PAPRICALAB

Venture Round in 2021
PAPRICALAB is a company co-founded by a radiation oncologist and a medical physicist.

Bioconnect

Venture Round in 2021
Bioconnect is a company that specializes in health management solutions by leveraging deep learning technology to collect user lifelogs. It operates as a data hub, connecting these lifelogs with various platforms that require medical information. The company has developed an application that allows users to monitor their health status and offers services such as vision-based biometric measurements, chronic disease management, and lab information management. Additionally, Bioconnect provides scientific document management, enabling users and healthcare providers to effectively track and manage health-related data.

Rapharad

Venture Round in 2021
RaphaRAD is a company focused on the development of advanced radiation therapy equipment aimed at improving oncology treatment. Founded by a radiation oncologist and five PhD experts in radiotherapy, the company designs devices that utilize in-body radiation therapy and advanced proton therapy technologies. These innovations are specifically engineered to minimize radiation exposure to surrounding healthy organs, thereby allowing healthcare professionals to treat and potentially cure cancer while reducing the side effects associated with radiation therapy. Through its commitment to enhancing cancer treatment, RaphaRAD strives to contribute to more effective and safer oncological care.

Hexa-Check

Venture Round in 2021
Hexa-Check offers original patents for the personal 6-channel ECG.

PLANB4U

Venture Round in 2021
PLANB4U provides a total solution for one's brain that comprises the whole cycle of brain health care.

V-Memory

Seed Round in 2020
V-Memory is a technology company specializing in semiconductor manufacturing solutions. It focuses on producing thermoelectric semiconductors aimed at enhancing the speed and density of memory cells. The company develops solid-state cooling semiconductors that offer higher efficiency, alongside advanced memory semiconductor technology that delivers improved performance. By providing next-generation semiconductor memory with extended longevity, V-Memory addresses energy distribution imbalances and meets the evolving demands of the technology sector.

Deep Embedded Technology

Venture Round in 2020
Deep Embedded Technology researches for the meeting of deep neural network (DNN) technology of artificial intelligence and Internet of Things technology.

sesu.ai

Venture Round in 2020
Sesu.ai is a digitalization platform focused on renewable energy, primarily aimed at enhancing solar power plant monitoring. The company provides a range of innovative solutions, including a virtual power plant that forecasts renewable energy usage and an IoT-based device for managing the production and consumption of renewable energy. Additionally, Sesu.ai offers a transaction and authentication distributed ledger that enables organizations to generate and authenticate power statistics, record original data related to power production and consumption, and supply essential management data. Through these offerings, Sesu.ai strives to promote the broader adoption of renewable energy and contribute to the development of a sustainable society.

Megnosis

Venture Round in 2020
Megnosis is a medical instrument manufacturing company focused on developing innovative neurological devices aimed at detecting and diagnosing brain lesion diseases. The company employs advanced technologies, including transcranial current stimulation and EEG-based electroceutical systems, to stimulate brain cells and the nervous system. These devices are designed to assist healthcare professionals in treating cognitive impairments and alleviating symptoms associated with conditions such as dementia and depression. Megnosis is committed to advancing the field of neurology through its cutting-edge products, which enhance patient care and improve treatment outcomes.

Baikal.ai

Venture Round in 2020
Baikal.ai is a company focused on cognitive health, specializing in the early detection of cognitive impairment through the analysis of spontaneous speech. Utilizing advanced deep learning solutions and natural language processing, the company aims to identify early signs of conditions such as Alzheimer's disease, Parkinson's disease, vascular dementia, and frontotemporal disorders. By listening to and analyzing users' speech patterns, Baikal.ai provides a platform that empowers patients to recognize potential health risks, facilitating timely intervention and care. The company's innovative approach combines artificial intelligence with a focus on user health, contributing to advancements in cognitive health assessment.

Molecular Bio-Technology

Venture Round in 2020
Molecular Bio-Technology improves molecular diagnostics products for Point-of-Care Testing and leads to the development of rapid and sensitive early diagnostics.

Gmeditec

Venture Round in 2020
Gmeditec is a manufacturer of medical devices focused on minimally invasive surgery. The company specializes in surgical navigation systems and balloon technology, which are integral to endoscopic procedures. Gmeditec has developed a hybrid surgical navigation system that utilizes both electromagnetic and optical location tracking, enhancing the precision and effectiveness of surgical interventions. By aligning clinical demand with research advancements, Gmeditec aims to drive innovation in the medical device sector, ultimately improving patient outcomes in minimally invasive surgical practices.

GhostPass

Venture Round in 2020
GhostPass is a startup that develops a biometric payment solution with A.I. and Self-Sovereign Identification technologies.

Phil Dave Music

Venture Round in 2020
Phil Dave Music started as a sheet music publishing and production company, and is currently making a leap into a Music Edu-Tech company.

DeepHelix

Venture Round in 2020
DeepHelix is an AI-driven biotechnology company specializing in the analysis of bio and healthcare data. It develops advanced diagnostic devices designed for healthcare professionals, particularly in the field of cancer diagnosis. Utilizing artificial intelligence, DeepHelix's technology can analyze medical images to assist doctors in identifying various diseases. The company's innovations aim to enhance the accuracy and efficiency of medical diagnoses, ultimately improving patient outcomes in the healthcare sector.

Wellcare

Venture Round in 2020
Wellcare is a digital livestock company that uses cylindrical IoT biocapsule source technology to collect and analyze the bio-data of livestock.

DC Medical

Venture Round in 2019
DC Medical Inc. is a medical device company based in Seoul, South Korea, founded in 2018. The company specializes in the development and commercialization of innovative medical devices aimed at enhancing patient care and improving quality of life. Its product offerings include Everybaby, a pregnancy diagnostic kit designed to identify the risk of premature birth, and a polypropylene mesh that is used for treating stress urinary incontinence, pelvic organ prolapse, and hernia surgery. DC Medical employs a unique No Research Develop Only (NRDO) business model, positioning itself as a pioneer in the South Korean medical device industry. Through its focus on advanced technology and patient-centered solutions, DC Medical aims to contribute to the improvement of healthcare standards and human dignity.

Institute of Blockchain Technology and Service

Venture Round in 2019
Institute of Blockchain Technology and Service launches EOS CHROME, a public blockchain with decentralization and scalability.

OPEL Solution

Venture Round in 2019
OPEL Solution is a company that specializes in enhancing road safety and driving efficiency through advanced analysis of driving behavior. It manufactures an onboard diagnostics (OBD) dongle that collects data from vehicle operation and assesses driving habits using artificial intelligence technology. The device scores drivers based on their behavior, identifies potentially dangerous situations such as drowsy driving, and provides real-time notifications to promote safer driving practices. The insights generated from this analysis are valuable to various stakeholders, including insurance companies, vehicle controllers, and maintenance providers, allowing them to support drivers in preventing accidents and improving overall road safety.

Andromeda

Venture Round in 2019
Andromeda Inc., established in 2015 and headquartered in Tokyo, Japan, operates a software application designed to help individuals reconnect with their school friends by finding, chatting, and matching them. The company has additional offices in Seoul, South Korea, and Jakarta Selatan, Indonesia. Andromeda's services are tailored to diverse cultures, reflecting the unique political and regional characteristics of its user base.

Handol Biotech

Venture Round in 2019
Handol Biotech develops nano-particles including the active ingredients such as drugs inside to be targeted into the special disease.

Gosohage

Venture Round in 2019
Gosohage Inc. is a legal technology company headquartered in Seoul, South Korea. It specializes in offering innovative legal platform services that leverage technology to enhance legal processes and accessibility. By focusing on law-tech solutions, Gosohage aims to streamline legal services, making them more efficient for users. The company's offerings are designed to meet the evolving needs of the legal industry, positioning it as a key player in the intersection of law and technology.

GHbio

Venture Round in 2019
GHbio is a biotechnology company.

Mirint

Venture Round in 2019
Mirint is a developer of an innovative portable device that utilizes low-power laser therapy to improve and prevent symptoms of allergic rhinitis. The company's lightweight and compact design ensures convenience for users, allowing easy portability. Mirint's device leverages advanced laser diffusion technology to enhance treatment effectiveness while integrating artificial intelligence to provide personalized prevention information. Users can connect the device to a dedicated application that enables them to monitor their usage and manage their allergic rhinitis more effectively.

Procagen

Venture Round in 2019
Procagen is a genetic analysis service company based in Seongnam-si, South Korea, specializing in the prediction of prostate cancer risk. By leveraging genetic biomarkers and advanced artificial intelligence, the company analyzes clinical, genomic, and imaging data to develop algorithms that assess the risk of prostate cancer. Procagen offers a quantitative risk score that helps identify potential patients at risk for the disease. In addition to risk assessment, the company provides genetic counseling and personalized prevention and screening plans aimed at early diagnosis and management of prostate cancer and related urinary diseases. Through its innovative approach, Procagen aims to enhance disease prediction and improve patient outcomes.

Biobankhealing

Venture Round in 2019
Biobankhealing develops innovative new drugs based on the intestinal microbial endoplasmic reticulum platform.

APEX AI

Venture Round in 2019
APEX AI is a healthcare technology company that specializes in the risk analysis and tracking of gastric cancer. It operates an AI-driven platform that combines deep learning algorithms with medical expertise to analyze patient data, predict cancer risks, and monitor disease progression. This enables healthcare providers to make informed, data-driven decisions, enhancing patient outcomes and facilitating personalized care management.

Oculight

Venture Round in 2019
Oculight is a manufacturer of medical devices specializing in innovations for cataract surgery. The company has developed an illumination chopper, a disposable surgical instrument that enhances the safety and efficacy of cataract procedures. By addressing challenging surgical conditions, Oculight aims to improve the overall outcomes for patients undergoing cataract surgery, providing medical professionals with reliable tools to facilitate their work.

J.R. Labs

Venture Round in 2019
J.R. Labs Inc. is a global biotechnology healthcare company based in Daejeon, South Korea, specializing in the production of recombinant proteins for medical applications. The company utilizes advanced technology to control specific gene expression and cellular metabolism through non-coding RNA (ncRNA). J.R. Labs develops molecular therapeutics that target oncogenic ncRNAs, as well as RNA vaccines designed to combat multidrug-resistant pathogenic bacteria and various cancers. Its products are available for purchase online, reflecting its commitment to providing innovative healthcare solutions.

CARBOEXPERT

Venture Round in 2019
CARBOEXPERT INC. is a South Korean company based in Daejeon, established in 2015. It specializes in the production and supply of functional carbohydrates and standard reference materials, primarily for the carbohydrate research field. The company's product offerings include Maltooligosaccharide, Cyclodextrin, Glucoside, and Polysaccharides. These products cater to various industries, including research, medicine, food, and cosmetics, and are available for purchase online. CARBOEXPERT's commitment to providing high-quality materials supports advancements in carbohydrate research and applications across multiple sectors.

Allcareable

Venture Round in 2019
Allcareable extracts essential biometric information in real-time from inpatient, clinical trial subjects, and anticancer drug users and analyzes using Deep Learning.

Peeper

Series A in 2018
Peeper is a social networking platform that facilitates direct interaction between fans and celebrities through a unique Q&A format. By allowing fans to pose questions to their favorite stars, Peeper offers a more engaging alternative to traditional social media channels. When a question garners significant interest, with over 10,000 fan requests, the star responds with personalized answers, often accompanied by voice messages and photos. This approach addresses the limitations of conventional platforms, which typically foster one-way communication, and instead encourages meaningful interactions. Peeper not only enables fans to seek answers from celebrities but also fosters a community where fans can connect with each other and share their favorite moments. By bridging the gap between stars and their followers, Peeper enhances the fan experience, making it more interactive and personal.

V-Memory

Venture Round in 2018
V-Memory is a technology company specializing in semiconductor manufacturing solutions. It focuses on producing thermoelectric semiconductors aimed at enhancing the speed and density of memory cells. The company develops solid-state cooling semiconductors that offer higher efficiency, alongside advanced memory semiconductor technology that delivers improved performance. By providing next-generation semiconductor memory with extended longevity, V-Memory addresses energy distribution imbalances and meets the evolving demands of the technology sector.

Innoregen

Venture Round in 2018
Innoregen is a company focused on the development and manufacture of bio-ink for 3D bioprinting. Its bio-ink products are designed for cell printing and polymer printing, combining cells, hydrogels, and polypeptides to create engineered and artificial living tissues. This innovative material enables tissue engineers to develop specific living tissues or organs, providing solutions for replacing damaged biological structures. Through its advanced bio-ink technology, Innoregen aims to contribute to the field of regenerative medicine and tissue engineering.

CuroGene Life Sciences

Venture Round in 2018
CuroGene Life Sciences Co., Ltd. is a pharmaceutical company based in Cheongju, South Korea, focused on the development and commercialization of adeno-associated virus (AAV)-based gene therapeutics. The company specializes in innovative treatments for age-related macular degeneration and diabetic retinopathy, both of which are prevalent eye disorders. By harnessing advancements in genetic biologics, CuroGene aims to provide effective solutions for patients suffering from these conditions, contributing to the evolving landscape of retinal therapies.

Medihub

Venture Round in 2018
Medihub is a medical technology company specializing in the development of an innovative automatic injector known as "i-Ject." This device is designed to enhance patient comfort by minimizing injection pain, while also streamlining the process for healthcare providers. Medihub's technology focuses on delivering dental local anesthesia with high accuracy in dosage and precision during procedures. The automatic syringe is equipped for continuous monitoring of drug delivery data across various medical fields, including medicine, vaccines, urology, dermatology, and plastic surgery. By reducing the risk of human error in manual injections, Medihub aims to improve patient outcomes and enhance the overall safety of medical procedures.

Procuratio

Venture Round in 2018
Procuratio is a company focused on enhancing health care through its innovative clinical patient monitoring platform. This platform automates the generation of alarms and reports, delivering real-time information to designated personnel, thereby improving patient oversight during clinical research. Procuratio specializes in the integration and management of clinical research data, offering solutions for data management and adverse event tracking. The company's expertise extends to developing Internet of Things (IoT) interlocking services tailored for clinical research, ensuring seamless operations in diverse research environments. Through these services, Procuratio aims to facilitate safer and more efficient clinical studies, ultimately benefiting patient care.

StemOn

Venture Round in 2018
StemOn Inc. is a biotechnology venture based in Seongnam-si, South Korea, established in 2018. The company specializes in developing innovative cellular reprogramming technology products aimed at creating advanced cell therapy solutions. Its flagship product, Ultra Repro, is an ultrasound reprogramming device that facilitates the secretion of exosomes from cells. This automated equipment enhances intercellular communication by delivering growth factors, cytokines, nucleic acids, and lipids to recipient cells, thereby streamlining the process for researchers who are working to prevent and manage diseases through cell therapy. StemOn is focused on reducing both the time and costs associated with producing a variety of exosomes, contributing to advancements in the field of regenerative medicine.

MK Meditech

Venture Round in 2018
MK Meditech provides clinical solutions in Orthodontics and OSAS treatment with a state-of-art palatal expansion appliance.

CdmoGen

Venture Round in 2018
CdmoGen is a company that specializes in the development and manufacturing of biopharmaceuticals and gene therapeutic products. It offers both GMP and non-GMP manufacturing services, as well as comprehensive GMP and GLP testing. The company focuses on virus-based advanced biopharmaceuticals, aiming to enhance gene and cell therapies. CdmoGen is dedicated to improving the quality evaluation and analysis of vaccine and viral biopharmaceuticals, ultimately helping patients access more effective virus-based gene therapies and drugs. Through its expertise in manufacturing and testing, CdmoGen plays a vital role in advancing the biopharmaceutical industry.

IMPACT KOREA

Venture Round in 2018
IMPACT KOREA provides medical pumps that can be applied to surgery, procedures, emergency patients, and intensive care units.

Genoheal

Venture Round in 2018
Genoheal collaborates R&D and research partnerships with clinical trial labs and pharmaceutical manufacturing and sales companies. The company focuses on new drug discovery based on technological excellence, the development of functional ingredients, and continuous research and development.

Cella Biotech

Venture Round in 2018
CELLA Biotech is a company focused on the development and manufacturing of medical devices and laboratory equipment. It offers a range of life science tools and diagnostic products designed to serve the entire industry. The company's capabilities include three-dimensional design, circuit design, software and firmware development, and prototype production. Additionally, CELLA Biotech provides services related to automation equipment and test analysis, enabling users to access advanced technological equipment within the biotechnology field. Through its innovative solutions, the company aims to support and enhance the bioindustry.

Wave-I

Venture Round in 2018
Wave-I is an independent entity that curates and produces art exhibitions that introduces the works of established and emerging artists.

Hessed Edu

Venture Round in 2018
Hessed Edu is an educational content platform focused on the development of STEAM (Science, Technology, Engineering, Arts, and Mathematics) materials. The company has created over 500 unique educational resources, which are utilized by 500 educational institutions catering to students aged 3 to 10 years. Hessed Edu's platform emphasizes the integration of humanistic imagination with scientific creativity, providing textbooks that facilitate step-by-step learning across a variety of subjects. This approach not only enhances academic knowledge but also promotes the development of good character among students.

V-Nature

Venture Round in 2018
V-Nature is a Greenbiology startup that manufactures ionized Vanadium, an anti-diabetic medical material with Insulin-mimic function.

Morethings

Venture Round in 2018
Morethings is a provider of innovative smart healthcare products aimed at enhancing the quality of life. The company specializes in intelligent sensing mats designed to elevate body practices such as yoga. These IoT-based mats not only assist with posture correction but also monitor sleep quality, capable of issuing emergency alerts if necessary. Morethings focuses on real-time data transmission and interactive education, equipping customers with tools that promote self-care and facilitate continuous learning. Through its advanced technology, the company aims to empower individuals to improve their well-being.

FEROKA

Venture Round in 2018
Feroka is a biotechnology company focused on advancing drug delivery systems through its innovative multi-layer microneedle patch platform. This technology is designed for precise delivery of vaccines and gene therapies by using micrometer-sized needles that can effectively penetrate various skin layers, including the epidermis and dermis. The microneedles rapidly melt upon application, allowing for the easy removal of the patch while ensuring that the drug is administered in exact volumes. This approach not only facilitates the treatment of conditions such as epidermolysis bullosa but also enhances the overall convenience and efficacy of drug delivery for various medical applications.

Y-IN

Venture Round in 2018
Y-IN Inc. is a South Korean company specializing in biocompatible and ultra-thin polymer coating services tailored for the medical industry. The firm develops advanced polymer materials and employs chemical vapor deposition (CVD) techniques to enhance the performance of various medical devices, including implants, surgical instruments, and ultrasound devices. In addition to its focus on healthcare, Y-IN also produces perylene vapor equipment for polymer applications across multiple sectors, such as electronics, automotive, aerospace, and military. By addressing challenges related to adhesion between perylene and product interfaces, the company provides innovative solutions that improve the functionality and longevity of coated products.

TRICUBICS

Angel Round in 2017
Tricubics offers 3D modeling service.

D EMPTYSPACE

Seed Round in 2017
D Emptyspace is a mobile application developed by DIFT Corp., which was founded in 2015 and is based in Seoul, South Korea. The application allows users to create immersive virtual galleries where they can customize their exhibition spaces using various templates. Users have the ability to invite friends and connect with other creators, fostering relationships among artists, critics, and collectors. D Emptyspace provides a platform for artists to curate their own spaces, share their stories, and present their work in a personalized manner. Additionally, the app facilitates the discovery of new and emerging artists, enhancing the overall experience of exploring and appreciating art in a virtual environment.

ARTIFEX

Venture Round in 2017
ARTIFEX is a production specialty company for the walking frame that helps elderly people who have difficulty moving around.

Shema

Venture Round in 2017
Shema develops and distributes smart masks for public health in a serious situations like air pollution.

KBioLab

Venture Round in 2017
KBioLab is a biotechnology company that helps build healthy lives through microorganisms.

Smart Checking Fixture

Venture Round in 2017
Smart Checking Fixture provides a 3D digital solution that enables the comparison of CAD data with the scan data of car parts.

Retrofit Korea

Venture Round in 2017
Retrofit Korea Co., Ltd., founded in 2015 and based in Ulsan, South Korea, specializes in engineering services for the power plant, shipbuilding, and marine industries. The company offers a range of solutions, including a Ballast Water Treatment System, offshore reverse engineering services, and consulting. Additionally, Retrofit Korea utilizes advanced technology such as the BLK360 image scanner to provide 3D spatial data and information essential for remodeling and repair projects. Currently, the company operates in stealth mode, focusing on delivering innovative engineering solutions to its clients.

Toysvill

Venture Round in 2017
Toysvill is an art community, a virtual and real space for creating personal artwork by coloring and crafting the platform toys.

Benedea

Venture Round in 2017
Benedea Inc. is a technology company based in Seoul, South Korea, founded in 2014. The company specializes in developing Han, a mobile input software that allows users to type simplified Chinese characters efficiently. This innovative software eliminates the need for users to convert pronunciations from the Roman alphabet into Chinese characters. In addition to its focus on Chinese input, Benedea also develops software for typing Japanese kanji, catering to the needs of users who require efficient input methods for both languages.

Tecozyme

Venture Round in 2017
Tecozyme Inc, based in Seoul, South Korea, specializes in developing innovative dental products designed to maintain a healthy oral ecosystem. Its portfolio includes self-cleaning dental implants, a photodynamic dental plaque removal healing abutment, zinc-based oral care products like Zinc Vita 21, and bad breath removal patches. These products aim to promote oral health by targeting bacteria, inflammation, and other oral disease-causing factors.

LARTBIO

Venture Round in 2017
LARTBIO is a transgenic animal development company focused on creating transgenic embryos from somatic cells. The company has developed innovative genetic scissors technology that is applicable to industrial bio-models. LARTBIO's capabilities include bovine fertilized egg transplantation and the development and supply of non-viral cell lines. Additionally, it specializes in producing genetically modified rats and creating functional milk and albumin through genetically modified cows. The company also engages in the development and production of animal pharmaceuticals and cosmetic materials, thereby facilitating commercialization opportunities in various markets, including functional milk, animals, and human applications.

kozaza.com

Venture Round in 2017
Kozaza Inc. is a home sharing platform based in Seoul, South Korea, specializing in a variety of unique and affordable accommodations, including homestays, apartments, guesthouses, and traditional Korean houses known as Hanoks. The name "Kozaza" reflects its mission to provide a restful experience, translating to "sleep well as baby" in Korean. Since its designation as a sharing company by the Seoul Metropolitan Government in 2013, Kozaza has partnered with local governments to promote a new culture of accommodation for foreign visitors. The platform emphasizes local service and cost-effectiveness, offering lower service fees and special promotions with local hosts. Kozaza aims to enhance the travel experience in Korea by providing diverse lodging options tailored to various preferences.

GaGyo Tech

Venture Round in 2017
GaGyo Tech develops a prototype of a non-Virus DBD plasma air purifier for vehicles. The company's patented technology generates a magnetic field by adding variable current to plasma and removing harmful substances.

SENSORTOPIA

Venture Round in 2017
SENSORTOPIA develops rain sensors that check the raindrop status and activate the automatic wiper system without any attention from the driver.

Ballop

Venture Round in 2017
Ballop is a local brand specializing in a diverse range of sports footwear and apparel, with a particular focus on aqua shoes for the Korean market. The company provides a variety of products, including shoes and clothing designed for different sports and seasonal conditions, as well as accessories tailored for water sports. By offering quality sports clothing suitable for all four seasons, Ballop aims to meet the needs of active consumers seeking functional and stylish athletic wear.

HANCOM MOBILITY

Venture Round in 2017
HANCOM MOBILITY develops IoT-enabled parking management solutions.

D&J Humancare

Venture Round in 2017
D&J Humancare helps people who are poor at managing their health to improve their health care.

Vovi C&E

Venture Round in 2017
Vovi C&E Co., Ltd., established in 2013 and headquartered in Seoul, South Korea, specializes in the research and development of bio raw materials with anti-bacterial and antioxidant properties. The company's primary product is Suda Calxy, a health functional food manufactured using ingredients beneficial to human health. Vovi C&E focuses on creating hydrogen-storing antioxidant bio-raw materials, aiming to provide innovative solutions in the hydrogen field while adhering to nature-friendly production methods.

InniTech

Venture Round in 2017
InniTech develops a golf distance measuring system for professional and amateur players.

Spryfit

Venture Round in 2016
Spryfit, Inc. is a fitness technology company based in Wilmington, Delaware, established in 2016. It offers a reward-based game platform that motivates users to achieve their fitness goals through collaboration and competition. The platform utilizes data from wearable devices and fitness applications, enabling participants to engage in fitness challenges and win cash prizes. By integrating health data and leveraging monetary incentives, Spryfit fosters virtual fitness communities that encourage users to meet their daily fitness objectives. The application automatically adjusts to local time zones and tracks various metrics such as step count, distance, and duration, making it a comprehensive tool for promoting a healthy lifestyle.

Infit & Company

Seed Round in 2016
Infit & Company Inc. is a manufacturer of medical diagnostic devices and wellness devices that targeting global healthcare industry.

L-base

Venture Round in 2016
L-Base is a biotechnology company focused on the development of innovative anti-cancer therapeutics, particularly autophagy inhibitors. The company aims to address the challenge of resistance to existing anticancer treatments by creating novel therapeutic agents that utilize CAGE-derived peptides. These agents are designed to enhance the effectiveness of targeted anticancer drugs while minimizing the side effects commonly associated with traditional chemotherapy. By concentrating on overcoming drug resistance, L-Base seeks to improve treatment outcomes for patients battling cancer.

Feagle

Venture Round in 2016
Feagle uses revolutionary transdermal drug delivery to enhance epidermal growth factors for treating skin problems.

ChemE

Venture Round in 2016
ChemE is a manufacturer of LCD, OLED, micro-LED, and electronic materials.

EIDWare

Venture Round in 2016
EIDWare develops embedded voice recognition software.

Olive Healthcare

Venture Round in 2016
Olive Healthcare is a company specializing in digital healthcare and medical diagnostic devices. It focuses on abdominal fat scanning and breast cancer diagnosis by utilizing non-radiative and non-invasive near infrared (NIR) technology. The company employs artificial intelligence algorithms and big data processing to deliver customized medical services. Olive Healthcare's devices not only measure abdominal fat but also offer personalized exercise and diet guidance based on individual health metrics. By providing these tailored services, the company aims to assist users in reducing belly fat and mitigating the risk of metabolic diseases.

Alpha Clo

Venture Round in 2016
Alpha Clo develops and sells two types of (B2B, B2C) products in order to differentiate from existing smart clothing products.

39 degrees C

Venture Round in 2016
39 degrees C is a media application development company that specializes in innovative video streaming solutions. Its flagship product, LILAY, is a multi-camera live streaming app that enables users to share camera screens between smartphones, facilitating real-time video shooting and transmission without the need for additional equipment. This app utilizes a unique technology known as WiFi-Direct, which has garnered numerous domestic and international patent licenses. In addition to LILAY, the company offers feedeo, a video-making application that provides users with a variety of stylish templates for content creation. Together, these applications empower users to host live streams and create engaging online stories for social media, making high-quality broadcasting accessible without the need for expensive recording setups.

Landymoss

Venture Round in 2016
Landymoss allows travelers to compare and choose hotels on their destinations.

Virocure

Venture Round in 2016
ViroCure, Inc. is a biopharmaceutical company based in Seoul, South Korea, specializing in the development of oncolytic viruses for cancer therapeutics and vaccine applications. The company focuses on creating and cataloging a range of naturally occurring, modified, and engineered viruses designed to selectively infect and destroy cancer cells while activating the body's anti-cancer immune response. ViroCure's product offerings include RC402, which targets metastatic gastric and lung cancers; RP116, effective against oral cancers, salivary gland cancer, soft tissue sarcoma, and melanoma; MC509, a rabbit-specific poxvirus; and SC717, which operates oncolytically in tumor-bearing animals. Through its innovative approaches, ViroCure aims to provide safer and more effective treatment options for cancer patients with minimal side effects on healthy cells.

Genesystem

Venture Round in 2016
Genesystem is a biotechnology engineering company focused on developing and marketing advanced molecular diagnostic devices. It specializes in state-of-the-art PCR platforms, reagents, and biochip products aimed at meeting on-site testing needs. The company is dedicated to enhancing public health and improving the quality of life through its innovative solutions. Additionally, Genesystem offers customized engineering services tailored to the biotechnology industry, leveraging its expertise to add value to clients' applications.

Roborus

Venture Round in 2016
Roborus, established in Seoul, South Korea in 2016, specializes in AI-driven smart ordering solutions for businesses. With over five decades of collective experience in AI, robotics, and international business, the company employs facial recognition technology to identify customers and enhance their ordering experiences. Their SaaS platform automates customer identification, collects data on visit frequency, consumption patterns, and spending habits, enabling restaurants to offer personalized services and recommendations based on customer profiles. Roborus has participated in the METRO Accelerator program powered by Techstars.

G+FLAS Life Sciences

Seed Round in 2016
G+FLAS Life Sciences Co., Ltd. is a South Korean biotechnology company founded in 2014, specializing in advanced genome editing technologies, particularly CRISPR-Cas. The company focuses on developing innovative agricultural products, most notably vitamin D3-enriched tomatoes, which aim to enhance nutritional value and cater to the growing demand for functional foods. By applying its proprietary CRISPR-PLUS technology, G+FLAS is able to create glycoengineered plants with improved health benefits, addressing critical market needs in both agricultural biotechnology and human health. The company also operates plant cultivation facilities for pharmaceuticals and engages in research related to anticancer therapies and drug development. Its strategic partnership with Bayer facilitates the commercialization of its technologies, positioning G+FLAS for significant growth in the global market. The company's innovations not only offer a sustainable, plant-based source of vitamin D3 but also target health-conscious consumers, aiming to capture a substantial share of the US tomato market, valued at approximately $18 billion. With its cutting-edge solutions, G+FLAS Life Sciences is poised to make a significant impact on global health and agricultural sustainability.

MEDITULIP

Venture Round in 2015
MEDITULIP is a manufacturer of medical devices focused on enhancing surgical procedures and cancer treatment. The company specializes in developing innovative tools for advanced minimally invasive surgery, including a unique asymmetrical linear stapler. This device is designed to facilitate the collection of tissue samples for frozen section biopsy from the true resection margin, allowing surgeons to verify the completeness of cancer surgery during the operation. MEDITULIP's products aim to improve surgical efficiency and support better patient outcomes in oncology.

WizMeta

Venture Round in 2015
WizMeta is developing a meta-video mash-up solution and plans to provide a global platform service based on the solution. The solution will help on-the-top (OTT) service providers to increase their revenue. By doing this, WizMeta aims to contribute to, and ultimately progress, the video industry and its respective market in a way that will enhance and improve the possibilities in which users interact with the video medium—a growth that will reinvent and revolutionize the way that we enjoy videos. Its defining technology is a patent that offers a new way of clipping and reviewing movies and videos. It is on how services can be offered so that users enjoy movies and videos by virtual clipping and review fast and seamlessly. We call such virtual clips, MetaVideos™. The company is building its accompanying tool, “MetaVideo™ Player” (MVP). MVP will serve as the fundamental platform for the services rendered by the patented technology. MVP will allow users to clip, mash up, and regenerate (i.e. define) content according to their particular interests and purposes. With the MVP, users will begin to clip, mash up and define movies and videos that may be available on YouTube, Vimeo, Hulu, Netflix, TED, Viki, MLB, ESPN, CNN, NBC, FOX, and so on, according to their respective interests and purposes. Subsequently, the users will share their defined clips, with friends and associates over social media.

IMGT

Venture Round in 2015
IMGT is a biotechnology company based in Seongnam-si, South Korea, founded in 2010. The company specializes in the development of drugs and therapeutic technologies that leverage nanotechnology for image-guided therapy. IMGT focuses on enhancing the precision and effectiveness of medical treatments by integrating advanced imaging techniques with innovative drug delivery systems. Through its research and development efforts, IMGT aims to improve patient outcomes and advance the field of biomedical technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.